Introduction
Feminizing adrenocortical tumours are rare, In a review of the world literature, Gabrilove et al. (1970) recorded 62 such cases in males and 5 cases in females. Since that date, 3 more cases affecting females have been published (Banich and Fox, 1970; Mathur et al., 1973; Golder et al., 1975) .
In the adult female, the clinical diagnosis of these tumours is difficult, probably because of the problem of recognizing the effects of extra-ovarian oestrogens.
In postmenopausal females complaining of vaginal bleeding, if endometrial carcinoma and feminizing ovarian tumour have been excluded with certainty, an adrenal tumour should be considered.
A case is now reported of a feminizing adrenal tumour diagnosed pre-operatively in a postmenopausal woman.
Case report
The patient was first treated for a toxic thyroid adenoma when she was 63 years old. At that time she was normotensive and had a normal intravenous urogram and ECG.
She presented again at the age of 69 years with a complaint of 2 months' vaginal bleeding. Her menopause had occurred at the age of 51 years.
On examination the breasts were atrophic, but the uterus was enlarged. The Fig. 1 . The total plasma oestrogens and plasma testosterone levels were high. Plasma gonadotrophin levels were very low. FSH and LH were measured by radioimmunoassay and plasma testosterone and total plasma oestrogens by methods described elsewhere (Edquist and Johansson, 1972; Forest, Cathiard and Bertrand, 1973) .
Plainchest and abdominal X-ray films were normal. (Fig. 2) . The ESR returned to normal. Two years after surgery the patient remains asymptomatic and well.
Discussion
Most feminizing adrenogenital syndromes reported to date occurred in males, and most of them have been produced by tumours (Gabrilove et al., 1965 (Gabrilove et al., , 1970 (Gabrilove et al., , 1973 Howard, Takahashi and Hayles, 1977) . The world literature yields only 8 cases of feminizing adrenal tumours in females, only 3 of them in postmenopausal women (Mathur et al., 1973; Golder et al., 1975; Monsaingeon, Camus and Ennuyer, 1963 outside of the capsule's (c) turnour (T), there was associated evidence of hirsutism and Cushing's syndrome (Monsaingeon et al., 1963) . In the prepubertal girl these tumours become manifest as precocious puberty. In the adult female of reproductive age their diagnosis is difficult until symptoms and signs of malignancy develop.
In the presence of vaginal bleeding in the postmenopausal female endometrial carcinoma is the most likely diagnosis and vaginal cytology, cervical dilatation and uterine curettage must be carried out. When this procedure yields an endometrial hyperplasia with high oestrogenic activity, hormonal determinations must be carried out to exclude the presence of feminizing ovarian or adrenal tumours or a gonadotrophin-producing tumour (Bjersing, Frankendal and Angstrom, 1973) . Details of feminizing adrenal tumours with high levels of chorioniclike gonadotrophin hormone in males have been published (Rose et al., 1968 (Solomon et al., 1968) .
Feminizing adrenal tumours usually produce oestriol and oestrone rather than the biologically more active oestradiol (Greenwood, 1974) .
In the present patient, plasma testosterone and the total plasma oestrogens, returned to normal after surgery. Plasma gonadotrophins have increased slightly soon after surgery. Two years after surgery the patient is asymptomatic and no evidence of metastasis is present.
Owing to the size and weight of the tumour in this case and the presence of multiple atypias and capsular invasion suggesting a malignant tumour, the authors deem it necessary to carry out a very careful follow-up procedure.
Postoperative recurrences will become manifest through renewed feminization, increase of the plasma oestrogens and the presence of local recurrence and distant metastasis (liver, lung, bone, etc.) .
In cases of recurrences or metastasis, treatment with o,p'-DDD (mitotane) may be of benefit (Monsaingeon et al., 1963; Solomon et al., 1968) . 
